Imagen de Portada
Código QR

The correlates and extent of prescribing of medications for alcohol relapse prevention in England.

Aims: To determine the pattern and extent of prescribing of medications for alcohol relapse prevention (ARP) in England. Design Cross‐sectional. Setting: Specialist drug and alcohol treatment providers in England reporting to the National Drug Treatment Monitoring System. Participants: Service users...

Descripción completa

Publicado en:Addiction Vol. 116; no. 11; pp. 3019 - 3027
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Nov2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=152818823&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 152818823
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09652140
        AIO
      jtl: Addiction
      issn: 09652140
      maglogo: Y
    pubinfo:
      dt: Nov2021
      vid: 116
      iid: 11
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        152818823
        150101673
        152818823
        152818823
        10.1111/add.15502
        152818823
      ppf: 3019
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: The correlates and extent of prescribing of medications for alcohol relapse prevention in England.
      aug:
      sug:
        subj:
          Alcoholism Drug Therapy
          Recurrence Prevention and Control
          Naltrexone Therapeutic Use
          Disulfiram Therapeutic Use
          Prescribing Patterns Evaluation
          Human
          Male
          Female
          England
          Cross Sectional Studies
          Descriptive Statistics
          Odds Ratio
          Confidence Intervals
          Logistic Regression
          Alcohol Abuse Drug Therapy
          Sex Factors
          Age Factors
          Ethnic Groups
          Substance Dependence
          Severity of Illness
          Geographic Factors
          Adult
          Adult: 19-44 years
          Male
          Female
      ab: Aims: To determine the pattern and extent of prescribing of medications for alcohol relapse prevention (ARP) in England. Design Cross‐sectional. Setting: Specialist drug and alcohol treatment providers in England reporting to the National Drug Treatment Monitoring System. Participants: Service users aged 18+, with alcohol the primary substance of dependence, completing a treatment journey between April 2013 and March 2016 (n = 188 152). Measurements Prescription of medications for ARP during a treatment journey. Data on service users' demographics, treatment and clinical characteristics were extracted. Findings The rate of prescribing medications for ARP was 2.1% in 2013/14, 6.8% in 2014/15 and 7.8% in 2015/16. A greater likelihood of prescription was associated with treatment journey year [2014/15; adjusted odds ratio (aOR) = 3.269, 95% confidence intervals (CI) = 3.044–3.510, 2015/16; aOR = 3.823, CI = 3.560–4.106], age (25–34; aOR = 1.622, CI = 1.380–1.907, 35–54; aOR = 1.901, CI = 1.628–2.220 or 55+; aOR = 1.700, CI = 1.446–1.999), female gender (aOR = 1.129, CI = 1.077–1.184), white ethnicity (aOR = 1.219, CI = 1.077–1.380), regional prevalence of alcohol dependence (middle rate; aOR = 1.121, CI = 1.024–1.228), severity of alcohol dependence (moderate dependence without complex needs; aOR = 1.329, CI = 1.244–1.419, severe dependence without complex needs; aOR = 1.308, CI = 1.188–1.441, moderate/severe dependence with complex needs; aOR = 1.131, CI = 1.020–1.255), treatment setting (inpatient; aOR = 10.512, CI = 9.950–11.104, primary care; aOR = 2.264, CI = 2.050–2.500, residential; aOR = 3.216, CI = 2.807–3.685), prior treatment for alcohol dependence (aOR = 1.242, CI = 1.183–1.304), longer treatment journey (aOR = 1.002, CI = 1.002–1.002), more drinking days in the prior 28 days (aOR = 1.021, CI = 1.018–1.024) and drinking a higher number of alcohol units in the prior 28 days (aOR = 1.002 CI = 1.001–1.004). Living in a region of England with the lowest alcohol prevalence was associated with a lower likelihood of prescription of medication for aRP (AOR = 0.491, CI = 0.436–0.552). Conclusions: In England, medications for alcohol relapse prevention are rarely prescribed (e.g. 7.8% in 2015/16) and those prescriptions appear to be associated with specific service user demographics, treatment and clinical characteristics.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N